The Yield of Amnioinfusion in the Prevention of Postpartum Hemorrhage
American Journal of Perinatology · 01.10.2025 · 42 (13) · 1771-1777
DOI: 10.1055/a-2535-8109 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.10.2025. Verfasst von Keren Zloto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel. Hauptthemen laut MEDLINE: Postpartum Hemorrhage. Die Arbeit nennt 18 Literaturangaben.
Abstract (Originalsprache)
Although amnioinfusion decreases the rate of uterine atony, its effect on postpartum hemorrhage (PPH) is uncertain. This study aimed to assess whether amnioinfusion reduces the risk of PPH in laboring individuals. A retrospective study of all laboring singletons at a tertiary center between January 2013 and December 2022 at ≥34 weeks. Individuals with known major fetal anomalies, stillbirths, or missing delivery records were excluded. The primary outcome was PPH. Neonatal and secondary maternal outcomes were also explored. Adjusted odds ratios (aOR) were estimated using multivariable regression models. Out of 113,816 deliveries during the study period, 83,152 (77.1%) met inclusion criteria, and among them 4,597 (4.03%) had amnioinfusion. Laboring individuals with amnioinfusion were more commonly nulliparous, had more polyhydramnios, oligohydramnios, preeclampsia, gestational diabetes, and fetal growth restriction. Furthermore, individuals with amnioinfusion had a higher rate of labor induction (54.54 vs. 27.8%; p < 0.01) and a higher cesarean rate (36.9 vs. 9.5%; p < 0.01). Following multivariable regression, there was no significant difference in the rate of PPH among individuals who had an amnioinfusion (2.6%) versus those who did not (3.1%; aOR: 0.95, 95% confidence interval [CI]: 0.87, 1.27). The rates of endometritis (aOR: 1.4; 95% CI: 1.04–1.89) and postpartum fever (aOR: 1.70; 95% CI: 1.36–2.12) were higher in those who had amnioinfusion compared with those that did not. Among laboring individuals ≥ 34 weeks, intrapartum amnioinfusion was not associated with a reduction in the rate of PPH and was associated with a higher likelihood of infectious morbidity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
- School of Medicine, Faculty of Medical and Health Sciences, Tel-Aviv University, Tel-Aviv, Israel.
- Division of Maternal-Fetal Medicine, Department of Obstetrics, Gynecology, and Reproductive Sciences, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, Texas.
Zitieren
APA
Zloto, K., Sivan, E., Yoeli-Ullman, R., Mazaki-Tovi, S., Chauhan, S. P., & Bartal, M. F. (2025). The Yield of Amnioinfusion in the Prevention of Postpartum Hemorrhage. American Journal of Perinatology, 42(13), 1771-1777. https://doi.org/10.1055/a-2535-8109
Vancouver
Zloto K, Sivan E, Yoeli-Ullman R, Mazaki-Tovi S, Chauhan SP, Bartal MF. The Yield of Amnioinfusion in the Prevention of Postpartum Hemorrhage. American Journal of Perinatology. 2025;42(13):1771-1777. doi:10.1055/a-2535-8109
BibTeX
@article{Zloto2025,
author = {Zloto, Keren and Sivan, Eyal and Yoeli-Ullman, Rakefet and Mazaki-Tovi, Shali and Chauhan, Suneet P and Bartal, Michal Fishel},
title = {The Yield of Amnioinfusion in the Prevention of Postpartum Hemorrhage},
journal = {American Journal of Perinatology},
year = {2025},
volume = {42},
number = {13},
pages = {1771--1777},
doi = {10.1055/a-2535-8109}
}
EUVIMED